Approval · Notice of Compliance 4669 · 1996
SAIZEN: Notice of Compliance 4669
Issued March 29, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4669
- Date
- March 29, 1996
- Company
- Serono Canada Inc.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Human growth hormone - growth stimulant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SAIZEN | 02215136 | Cancelled Post Market |
Medicinal ingredients
- SOMATROPIN 10 UNIT per VIAL